Publication:
Hepatitis E Virus (HEV) Infection in Anti-HEV Immunoglobulin G-Carrying Patients After Successful Hepatitis C Virus Treatment: Reactivation or Reinfection?

Simple item page
dc.contributor.authorRivero-Juarez, Antonio
dc.contributor.authorFrias, Mario
dc.contributor.authorLopez-Lopez, Pedro
dc.contributor.authorde Los Angeles Risalde, María
dc.contributor.authorBrieva, Teresa
dc.contributor.authorMachuca, Isabel
dc.contributor.authorCamacho, Angela
dc.contributor.authorMartinez-Peinado, Antonio
dc.contributor.authorGomez-Villamandos, Jose Carlos
dc.contributor.authorRivero, Antonio
dc.date.accessioned2023-01-25T09:42:58Z
dc.date.available2023-01-25T09:42:58Z
dc.date.issued2017-01-03
dc.description.abstractAlthough hepatitis E virus (HEV) is regarded as a self-limiting infection and anti-HEV antibodies seem to protect against reinfection, its pathogenesis is not well established. We describe 2 cases of acute symptomatic HEV infection after hepatitis C therapy in patients carrying anti-HEV immunoglobulin G antibodies, raising 2 major questions: reactivation or reinfection?
dc.identifier.citationRivero-Juarez A, Frias M, Lopez-Lopez P, de Los Angeles Risalde M, Brieva T, Machuca I, et al. Hepatitis E Virus (HEV) Infection in Anti-HEV Immunoglobulin G-Carrying Patients After Successful Hepatitis C Virus Treatment: Reactivation or Reinfection? Clin Infect Dis. 2017 Apr 1;64(7):964-966
dc.identifier.doi10.1093/cid/cix004
dc.identifier.essn1537-6591
dc.identifier.pmid28077520
dc.identifier.unpaywallURLhttps://academic.oup.com/cid/article-pdf/64/7/964/11014311/cix004.pdf
dc.identifier.urihttp://hdl.handle.net/10668/10766
dc.issue.number7
dc.journal.titleClinical infectious diseases : an official publication of the Infectious Diseases Society of America
dc.journal.titleabbreviationClin Infect Dis
dc.language.isoen
dc.organizationHospital Universitario Reina Sofía
dc.organizationInstituto Maimónides de Investigación Biomédica de Córdoba-IMIBIC
dc.page.number964-966
dc.publisherOXFORD ACADEMIC
dc.pubmedtypeCase Reports
dc.pubmedtypeJournal Article
dc.rights.accessRightsopen access
dc.subjectHIV
dc.subjectHepatitis C
dc.subjectHepatitis E
dc.subjectReactivation
dc.subjectReinfection
dc.subject.decsActivacion Viral
dc.subject.decsAnciano
dc.subject.decsAnticuerpos antihepatitis
dc.subject.decsAntivirales
dc.subject.decsCarga Viral
dc.subject.decsCoinfeccion
dc.subject.decsFemenino
dc.subject.decsHumanos
dc.subject.decsInfecciones por VIH
dc.subject.meshAged
dc.subject.meshAntiretroviral Therapy, Highly Active
dc.subject.meshAntiviral Agents
dc.subject.meshCoinfection
dc.subject.meshFemale
dc.subject.meshHIV Infections
dc.subject.meshHepatitis Antibodies
dc.subject.meshHepatitis C
dc.subject.meshHepatitis E
dc.subject.meshHepatitis E virus
dc.subject.meshHumans
dc.subject.meshImmunoglobulin G
dc.subject.meshImmunoglobulin M
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshViral Load
dc.subject.meshVirus Activation
dc.titleHepatitis E Virus (HEV) Infection in Anti-HEV Immunoglobulin G-Carrying Patients After Successful Hepatitis C Virus Treatment: Reactivation or Reinfection?
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number64
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
RISalud_Accesorestringido.pdf
Size:
93.39 KB
Format:
Adobe Portable Document Format
Download

Collections

SAS - Hospital Universitario Reina Sofía
Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía